ESR1 and breast carcinoma: The resulting subtypes can be clinically relevant as in the case of breast cancer where the presence of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor (HER2) within the tumor directly impacts prognosis and treatment strategy [133].